[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100514989":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":10,"locations":15,"responsibleParty":34,"collaborators":36,"id":40,"slug":41,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":44,"acronym":10,"eligibilityCriteria":45,"healthyVolunteers":46,"sex":47,"minAge":48,"maxAge":10,"enrollmentInfo":49,"targetDuration":10,"studyType":52,"phases":10,"briefSummary":53,"conditions":54,"keywords":58,"overallStatus":18,"whyStopped":10,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},{"fullName":5,"class":6},"Region Stockholm","OTHER_GOV",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Suspected",null,"Suspected Platelet Function Disorder during bleeding investigation",{"label":13,"type":10,"description":14,"interventionNames":10},"Confirmed","Confirmed Platelet Function Disorder by Functional or Genetic Assay, or confirmed negative by gold standard assay",[16],{"facility":17,"status":18,"city":19,"state":10,"zip":10,"country":20,"countryCode":21,"cosmosGeoPoint":22,"geoPoint":27,"contacts":28},"Karolinska University Hospital","RECRUITING","Stockholm","Sweden","SE",{"type":23,"coordinates":24},"Point",[25,26],18.06871,59.32938,{"lat":26,"lon":25},[29],{"name":30,"role":31,"phone":32,"phoneExt":10,"email":33},"David Schmidt, MD, PhD","CONTACT","0812370000","david.schmidt@regionstockholm.se",{"type":35,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[37],{"name":38,"class":39},"Karolinska Institutet","OTHER","100514989","towards-improved-diagnostics-for-suspected-platelet-function-disorders-100514989",false,"NCT05985668","Towards Improved Diagnostics for Suspected Platelet Function Disorders","Inclusion Criteria, known defects:\n\n* Known platelet function disorder under follow-up at Karolinska University Hospital (genetic or functional assay)\n* High likelihood of platelet function disorder (aberrant screening test with inheritance)\n* Family investigation for platelet disorder\n\nExclusion Criteria, known defects::\n\n* Antiplatelet or anticoagulant drugs\n* vWF:GPIb below 0.40 IU\u002FmL\n* Hematocrit below 0.35 or above 0.50\n* Other coagulation disorder\n\nInclusion Criteria, suspected platelet function disorder:\n\n* Bleeding investigation at Karolinska University Hospital\n\nExclusion Criteria, suspected platelet function disorder::\n\n* Antiplatelet or anticoagulant drugs\n* vWF:GPIb below 0.40 IU\u002FmL\n* Hematocrit below 0.35 or above 0.50\n* Other coagulation disorder",true,"ALL","12 Months",{"count":50,"type":51},140,"ESTIMATED","OBSERVATIONAL","This study aims to improve platelet function testing during bleeding investigations. To this end, the study will evaluate the diagnostic accuracy of novel platelet function tests in patients with confirmed or suspected platelet function disorders. Study participants will be recruited from patients that are referred to or treated at the Coagulation Unit, Karolinska University Hospital, and Pediatric Coagulation Unit, Astrid Lingren Children's Hospital.",[55,56,57],"Platelet Function Disorder","Platelet Disorder","Thrombocytopathy",[59],"diagnostic accuracy","2023-12-01",{"date":62,"type":63},"2023-12-04","ACTUAL",{"date":65,"type":63},"2023-09-05",{"date":67,"type":51},"2026-12-31",{"name":5,"class":6},1]